Together, these data are consistent with a potentially causative SLE molecular mechanism involving an allele-dependent enhancer consisting of stronger direct binding of ELF1 to the ‘A’ risk allele, along with indirectly altered binding of multiple additional TFs to this locus. The gene discussed is ELF1; the disease is systemic lupus erythematosus.